Quantum BioPharma News - November 2026

🟢 Quantum BioPharma is trading 18% up in pre-market with no clear catalyst identified

Quantum BioPharma is trading at $2.48, up 17.53%, in pre-market, with no clear catalyst identified. - The company filed a supplement ahead of its November 10...

Quantum BioPharma Ltd. Q3 2026 Earnings Preview: What Analysts Expect on November 06, 2026

For the third quarter of 2026, analysts expect Quantum BioPharma Ltd. to report a consensus loss of $0.50 per share on $0.00 in revenue, as the stock trades at...